BergenBrain wants to make research accessible to both academic communities and the general public. Through media and dissemination, we share new knowledge to strengthen the understanding of neurological diseases.
Media (2025)
Migraine, women's health and research: new episode of DRIVpodden with Marte Bjørk!
JAMA Podcast (2025)
Professor Nils Erik Gilhus and UCB Pharma CEO Fredrik Arneberg point out that Norway should take inspiration from the Netherlands when it comes to handling rare diseases and access to expensive treatments. Arneberg emphasizes that the specific nature of the disease, such as myasthenia gravis, is often not captured by today's QALY methodology, and that there is therefore a need to find a middle ground that both patients and the healthcare system can live with.
Article (2025)
During EAN 2025, Professor Emeritus Nils Erik Gilhus (University of Bergen / HUS) gave a presentation at the Nordic Evening. He provided an overview of different perspectives on myasthenia gravis, with particular emphasis on the development and implementation of new treatments. Gilhus pointed out that the field is facing a fundamental shift in the treatment of the disease.
Interview (2025)
At the EAN Congress 2025 in Helsinki, a dedicated Mentorship Workshop will once again be held, highlighting the importance of mentoring in the neurology community. Professor Nils Erik Gilhus, who has been a mentor in the program since its inception, shares his experiences and highlights how the arrangement has provided mutual learning, collaboration and lasting professional connections.
Podcasts (2025)
During the 2024 European Academy of Neurology (EAN) Congress in Helsinki, EAN President Elena Moro interviewed Professor Nils Erik Gilhus. At the same congress, Professor Gilhus from BergenBrain was elected an honorary member of the EAN and selected to deliver the prestigious Moritz Romberg Lecture.
Interview (2024)
At the EAN Congress 2024 in Helsinki, Professor Nils Erik Gilhus (UiB/Haukeland) was interviewed by EMJ Neurology. He shared experiences from a long career in neurology and lectured on individualized treatment of myasthenia gravis in the prestigious Moritz Romberg Lecture.
Podcast (2024)
Nils Erik Gilhus talks about disorders of the neuromuscular junction: The relevance of autoantibodies for the treatment of generalized myasthenia gravis.
Podcasts (2025)
Join Professor Nils Erik Gilhus, and a panel of experts on myasthenia gravis (MG), as they discuss a wide range of medical and clinical challenges related to MG.
Podcasts (2025)
Join Professor Nils Erik Gilhus and a panel of experts as they discuss a wide range of medical and clinical challenges in the treatment of myasthenia gravis (MG).
Newspaper article (2025)
This year, the Epilepsy Association has awarded over 400,000 kroner to three research projects – and one of them is the EPI-NY study led by Senior Consultant Jan Brøgger at the Department of Neurophysiology, HUS.
Podcasts (2025)
Marte-Helene Bjørk is interviewed by Lancet Neurology about women and epilepsy (2025)
Bergen Newspaper (2024)
Report about migraine patient Dorthe Willemann at Haukeland, who got her life back with botox treatment.
Newspaper article (2025)
Mahendran Jayaraman is interviewed about his lecture on his doctoral thesis on women and migraine (BA, 2025)
Newspaper article (2025)
Karine Eid was one of 21 Norwegian researchers who were allowed to travel to the United States (Khrono, 2025)
Video interview (2024)
Jenny Linnea Victoria Lindroos cites the findings from her cohort study that examined birth and neonatal outcomes in a national cohort of patients with myasthenia gravis (MG) (VJNeurology, 2024)
Video interview (2024)
Jenny Linnea Victoria Lindroos outlines future goals in the treatment of myasthenia gravis (MG) with regard to pregnancy and newborns (VJNeurology, 2024).
Video interview (2025)
Jenny Linnea Victoria Lindroos talks about managing pregnancy with myasthenia gravis (MG)
Psych Interesting (2024)
Marte-Helene Bjørk and Yvonne Myrtvedt Wollertsen talk about epilepsy and mental health
JAMA Podcast (2022)
Marte-Helene Bjørk talks about prenatal exposure to antiepileptic drugs and the risk of autism and intellectual disability.
JAMA Podcast (2018)
Marte-Helene Bjørk talks about maternal folic acid supplementation and the risk of autistic traits after exposure to antiepileptic drugs.
BergenBrain Clinical Department 1, University of Bergen Jonas Lies Road 91, 5020 Bergen, Norway
